Transgenic models of heart failure: elucidation of the molecular mechanisms of heart disease

Affiliations

Review

Djamel Lebeche et al. Heart Fail Clin. 2005 Jul.

. 2005 Jul;1(2):219-36.

doi: 10.1016/j.hfc.2005.03.005.

¹ Massachusetts General Hospital, Charlestown, MA 02129, USA. dlebeche@partners.org

No abstract available

Similar articles

Learning from failure: congestive heart failure in the postgenomic age.
Benjamin IJ, Schneider MD. Benjamin IJ, et al. J Clin Invest. 2005 Mar;115(3):495-9. doi: 10.1172/JCI24477. J Clin Invest. 2005. PMID: 15765130 Free PMC article. Review.
[Contribution of transgenesis models in discovery of new pharmacological targets in heart failure: aldosterone receptor as an example].
Latouche C, Jaisser F. Latouche C, et al. Therapie. 2009 Mar-Apr;64(2):81-6. doi: 10.2515/therapie/2009024. Epub 2009 Aug 11. Therapie. 2009. PMID: 19664400 Review. French.
Microarray analysis to evaluate different animal models for human heart failure.
Ruiz P, Witt H. Ruiz P, et al. J Mol Cell Cardiol. 2006 Jan;40(1):13-5. doi: 10.1016/j.yjmcc.2005.09.010. Epub 2005 Nov 9. J Mol Cell Cardiol. 2006. PMID: 16288911 No abstract available.
Bibliography. Current world literature. Molecular genetics.
[No authors listed] [No authors listed] Curr Opin Cardiol. 2000 May;15(3):B136-49. Curr Opin Cardiol. 2000. PMID: 10952431 No abstract available.
A new approach for the identification of modifier genes in heart failure.
Komajda M, Charron P. Komajda M, et al. Pharmacogenomics J. 2004;4(4):221-3. doi: 10.1038/sj.tpj.6500257. Pharmacogenomics J. 2004. PMID: 15159767 No abstract available.